Zijiang Enterprise set up a packaging company in Hubei with 20 million yuan. According to the enterprise search APP, Hubei Zijiang Packaging Co., Ltd. was recently established, with Shao Chunjiang as the legal representative and a registered capital of 20 million yuan. Its business scope includes: the production of plastic packaging containers and tools for food; Sales of plastic packaging containers, tools and products for food. Enterprise investigation shows that the company is wholly owned by Zijiang Enterprise.The Nikkei 225 index fell to 1%.Xray, an important partner of Yizhizhuang, officially announced a strategic cooperation with Google. According to Yizhizhuang, at the Android XR conference held in new york, Google officially announced a strategic cooperation with Xray to jointly build the Android XR ecosystem. This cooperation not only highlights XREAL's position as the world's largest manufacturer of AR glasses, but also marks a new stage of accelerated popularization of XR industry. It is noteworthy that Lingyizhi, as a long-term strategic partner of XREAL, provides key components and assembly services for XREAL AR glasses.
Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.Leader of the largest opposition party in South Korea: Impeachment is the most reliable way to end the chaos. Li Zaiming, leader of the Common Democratic Party, the largest opposition party in South Korea, said in a statement on the 13th that impeachment is the quickest and most reliable way to end the chaos. Li Zaiming said that President Yin Xiyue tried to cover up the crime with lies, and Yin Xiyue, the "culprit of civil strife", should step down immediately. He also called on members of the ruling National Power Party to vote in favor of the second vote of the presidential impeachment motion on the 14th. (Xinhua News Agency)The United States ITC officially launched a 337 investigation on injection molding machines, their components and downstream products. According to China Trade Relief Information Network, on December 12, the United States International Trade Commission (ITC) voted to launch a 337 investigation (investigation code: 337-TA-1427) on specific injection molding machines, their components and downstream products.
The concept of starting economy continued to strengthen, and the direction of exhibition and IP economy led the rise. Miao Exhibition, Liard and Guangbo shares rose daily, Fengshang Culture and Zhongqingbao rose by more than 10%, and Tianxiaxiu, Dafeng Industry, Silk Road Vision and Aoya shares were among the top gainers.Hong Kong stocks opened lower, with the Hang Seng Technology Index falling to 2% and the Hang Seng Index falling 1.76%.Hong Kong stocks opened lower, with the Hang Seng Technology Index falling to 2% and the Hang Seng Index falling 1.76%.
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
Strategy guide